Illumina (ILMN) wins its motion for dismissal in its patent litigation with Helicos BioSciences (HLCS), which was filed against the company in October 2010. The judge ruled the patent was invalid for inadequate written description. It was the last remaining one to be dismissed by the court, out of three separate patents originally asserted by Helicos in the lawsuit.
Illumina (ILMN) wins its motion for dismissal in its patent litigation with Helicos BioSciences...
From other sites
Video at CNBC.com (Jun 28, 2016)
Video at CNBC.com (Apr 19, 2016)
Video at CNBC.com (Oct 6, 2015)
at CNBC.com (Jan 9, 2015)
at CNBC.com (Dec 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs